Oxygen at Night: Workup and Coverage

Nocturnal hypoxemia is common, consequential, and — when it comes to getting oxygen paid for — procedurally unforgiving. Dr. Vishal Saini lays out a clean workup for sleep-related desaturation with and without comorbid sleep apnea, then walks through exactly how to meet Medicare and BCBSM requirements so the oxygen your patient needs actually gets covered.

By Dr. Vishal Saini, M.D., FAASM — Research & Medical Director, Mid-West Center for Sleep Disorders

Few things are more frustrating in practice than correctly identifying that a patient desaturates at night, prescribing the oxygen they clearly need, and then watching the claim bounce back denied. The clinical part and the coverage part of nocturnal hypoxemia are two different skills, and you have to get both right. This piece is a practical guide to each — first the workup, with and without comorbid obstructive sleep apnea (OSA), then the specific Medicare and Blue Cross Blue Shield of Michigan (BCBSM) requirements that decide whether the oxygen gets paid for.

Step One: Is It Hypoxemia, Hypoventilation, or Apnea?

The single most important conceptual move is to separate three things that overnight pulse oximetry can blur together.

Nocturnal hypoxemia is a low oxygen saturation during sleep. Hypoventilation is inadequate ventilation with CO₂ retention — and crucially, oximetry does not measure CO₂, so you can miss it entirely if you only look at an oximetry tracing. Obstructive sleep apnea produces its own characteristic intermittent, event-related desaturations. These overlap constantly, and the treatment implications diverge sharply: apnea calls for positive airway pressure (PAP), hypoventilation calls for ventilation (bilevel/NIV), and only genuine sleep-related hypoxemia that persists after those are addressed calls for supplemental oxygen.

This matters for patient safety, not just billing. Giving oxygen alone to a patient who is actually hypoventilating — in obesity hypoventilation syndrome, advanced COPD, or neuromuscular disease — can blunt respiratory drive and worsen hypercapnia. Oxygen is not a substitute for ventilation, and it is not a substitute for PAP.

So the first question in any nocturnal-desaturation workup is: what is actually driving the low number?

"A pulse oximeter is a wonderful screening tool and a terrible diagnostician on its own. It tells you the saturation fell — it doesn't tell you whether the problem is a collapsing airway, a failing bellows, or diseased lung. Those three answers lead to three different prescriptions, and only one of them is oxygen." — Dr. Vishal Saini

The Workup Pathway

Here's how I approach it in sequence.

History and exam. Who desaturates at night? Think COPD and interstitial lung disease, obesity hypoventilation syndrome, neuromuscular and chest-wall disease, pulmonary hypertension, and heart failure — alongside, or on top of, OSA. Ask about morning headaches (a hypoventilation clue), witnessed apneas and snoring (apnea), orthopnea and edema (cardiac), and exertional dyspnea. Look for signs of cor pulmonale.

Daytime baseline. Resting awake oximetry and, when the picture is unclear or hypoventilation is suspected, an arterial blood gas. Pulmonary function testing and an echocardiogram (for pulmonary hypertension) round out the non-sleep evaluation. The awake resting values also matter enormously for coverage, as you'll see — the qualifying pathway is different depending on whether the patient is hypoxemic while awake or only during sleep.

Overnight oximetry — read the pattern, not just the nadir. High-resolution nocturnal oximetry is the workhorse screening test. Beyond the lowest saturation, the shape is diagnostic: a repetitive sawtooth of brief dips suggests apnea, whereas sustained, plateau-like desaturation (often worst in REM) points toward parenchymal disease or hypoventilation.

Add CO₂ when hypoventilation is on the table. If the history, a high bicarbonate, or a sustained-desaturation pattern raises concern for hypoventilation, you need CO₂ data — transcutaneous or end-tidal capnography during a sleep study, or an ABG. This is the step most often skipped, and the one that most often changes management.

Characterize the apnea. If OSA is plausible, get the diagnosis properly — in-lab polysomnography (ideal when hypoventilation or complex disease is suspected, since it can include CO₂ monitoring) or a home sleep apnea test in straightforward cases.

With Comorbid OSA: Treat the Apnea First

When nocturnal hypoxemia coexists with OSA — the classic example being COPD plus OSA, the "overlap syndrome" — the sequence is non-negotiable, both clinically and for coverage: treat the apnea first, then reassess.

Start PAP, confirm it's controlling the respiratory events and that the patient is actually using it, and then repeat the nocturnal oximetry on PAP. In many patients, the desaturations resolve once the airway is stabilized, and no oxygen is needed at all. In others, a residual sleep-related hypoxemia persists despite well-titrated, adherent PAP — and that is the patient for whom supplemental oxygen, typically bled into the PAP circuit, is both appropriate and defensible.

The documentation logic follows the clinical logic. Payers will not cover oxygen as a treatment for sleep apnea — the covered therapy for apnea is PAP. So if your only qualifying desaturation is occurring during untreated apneic events, an oxygen claim is on thin ice. Demonstrating that the apnea is diagnosed and treated, and that hypoxemia persists on therapy, is what makes the oxygen medically necessary rather than a workaround for untreated OSA.

Without OSA: Isolated Sleep-Related Hypoxemia

When apnea is absent or excluded, you're dealing with sleep-related hypoxemia (or hypoventilation) from the underlying cardiopulmonary or neuromuscular disease itself. Here the overnight oximetry — showing the patient meets the nocturnal qualifying thresholds below — is usually the pivotal test, provided it's performed and documented correctly.

Two cautions. First, again, rule in or out hypoventilation with CO₂ monitoring, because a hypercapnic patient (OHS, neuromuscular disease, advanced COPD) generally needs bilevel ventilation, with oxygen added only if hypoxemia persists on adequate ventilation. Second, make sure the qualifying study reflects the patient's stable baseline, not an acute exacerbation — which, as we'll see, is also a coverage requirement.

Getting It Covered: Medicare

Medicare's rules for home oxygen are set by National Coverage Determination (NCD) 240.2 and the DME-MAC Local Coverage Determination (LCD L33797). They are specific, and denials almost always trace to missing one of these elements.

The qualifying numbers. Medicare sorts patients into groups:

Group I includes three relevant pathways. At rest, awake: PaO₂ ≤ 55 mm Hg or SpO₂ ≤ 88% on room air. During sleep: PaO₂ ≤ 55 mm Hg or SpO₂ ≤ 88% in a patient whose awake values are ≥ 56 mm Hg / ≥ 89% — this is the pure nocturnal-qualification pathway. Alternatively, a sleep-related drop of more than 10 mm Hg in PaO₂ or more than 5% in SpO₂ from baseline, associated with symptoms or signs attributable to hypoxemia (impaired cognition, nocturnal restlessness, insomnia). For both sleep pathways, coverage is for oxygen during sleep only — a portable unit is not covered on a nocturnal qualification.
Group II covers PaO₂ of 56–59 mm Hg or SpO₂ of 89% plus one of: dependent edema suggesting CHF, pulmonary hypertension/cor pulmonale (by measurement, echo, or P pulmonale on EKG — P wave > 3 mm in II, III, or aVF), or erythrocythemia with hematocrit > 56%.

Who may perform the test — and who may not. The qualifying blood gas or oximetry must be ordered and evaluated by the treating practitioner and performed by the practitioner or a qualified laboratory provider. A DME supplier is explicitly not a qualified provider of these laboratory services — a qualifying test run by the oxygen company will not count. If an ABG and oximetry conflict, Medicare treats the ABG as the preferred evidence.

Timing — the "time of need." The study must be done at the time of need — during the illness when home oxygen is expected to help. For a hospitalized patient, that means within two days of discharge; the test should reflect the stable condition, not an acute exacerbation that will resolve.

Paperwork. A Standard Written Order (SWO) must reach the supplier before the claim — and note that the old CMS-484 Certificate of Medical Necessity was retired for oxygen as of January 2023, so the burden now sits on a complete SWO plus thorough medical-record documentation of the qualifying test, the diagnosis, and medical necessity. Home oxygen is a capped-rental benefit, and continued coverage requires ongoing documentation of need (with repeat testing where the group criteria require it).

One more Medicare nuance worth knowing: the policy now explicitly directs that the record address factors that affect oximetry accuracy — age, altitude, and notably skin pigmentation — a response to well-documented pulse-oximeter inaccuracy in patients with darker skin. When a reading is borderline, a confirmatory ABG protects both the patient and the claim.

Getting It Covered: BCBSM

The good news for Michigan clinicians is that BCBSM's Home Oxygen Equipment medical policy aligns with Medicare's NCD 240.2 criteria — the same Group I/II thresholds, the same qualifying-test logic — a position BCBSM has stated explicitly, with the main difference being that BCBSM does not apply Medicare's 36-month rental cap. BCBSM and Blue Care Network also follow CMS guidance directly when making organization determinations for their Medicare Advantage members.

Practically, that means the nocturnal criteria you're documenting for Medicare are the same ones BCBSM expects: for example, BCBSM's policy recognizes a sleep-related desaturation of more than 5% from baseline lasting at least five minutes with associated symptoms — a useful reminder that a qualifying nocturnal event should be sustained and symptomatic, not a single transient dip. Two action items specific to BCBSM: confirm the member's DME benefit (coverage ultimately rides on the individual plan's durable-medical-equipment terms), and check whether prior authorization is required for that product and plan before delivery. When in doubt, pull the current "Home Oxygen Equipment and Related Supplies" policy from the BCBSM Medical Policy Router rather than relying on memory, since these policies are periodically updated.

A Denial-Proofing Checklist

Before the oxygen order goes out, I run through this:

Right test, right performer: qualifying ABG or oximetry ordered and evaluated by the treating practitioner and performed by the practitioner or a qualified lab — never the DME supplier.
Right conditions: stable baseline, not an exacerbation; room air; awake and asleep values documented so the correct Group I pathway is clear.
Apnea addressed: if OSA is present, it's diagnosed and treated with PAP, and the qualifying hypoxemia is documented as persisting on therapy.
Hypoventilation excluded or treated: CO₂ assessed when suspected; bilevel rather than oxygen alone when the patient is hypercapnic.
Numbers meet a named pathway: the chart states which Group I or Group II criterion is met, with the actual values.
Paperwork complete: SWO to the supplier before the claim; medical-record documentation of test, diagnosis, and necessity; borderline oximetry backed by ABG, with a note on accuracy factors where relevant.
Payer specifics: Medicare nocturnal qualification = sleep-only coverage, no portable; for BCBSM, verify DME benefit and prior-auth.

The Bottom Line

Nocturnal hypoxemia is really three questions wearing one number: is this apnea, hypoventilation, or true sleep-related hypoxemia? Sort that out first — treat apnea with PAP, hypoventilation with ventilation, and reserve oxygen for the hypoxemia that remains — and both your clinical decision and your documentation fall into place. On the coverage side, Medicare's NCD 240.2 and BCBSM's aligned policy are demanding but entirely navigable: qualify the patient on a named Group I or Group II pathway with a properly performed test, exclude untreated apnea and hypoventilation, and get the standard written order and records in order before the claim. Do that, and the oxygen your patient needs at night is both the right therapy and a paid one.

Dr. Vishal Saini, M.D., FAASM is the Research & Medical Director at Mid-West Center for Sleep Disorders, which operates its own sleep laboratories and evaluates sleep-related hypoxemia, hypoventilation, obstructive and central sleep apnea, and complex sleep disorders — with in-lab CO₂ monitoring and attended titration — in Lansing, Traverse City, and Eaton Rapids.

Have a patient who desaturates at night and you're not sure whether it's apnea, hypoventilation, or hypoxemia — or how to get the therapy covered? Refer them to us; we'll sort out the physiology and the paperwork.

Refer a Patient / Book a Consultation → | (517) 887-6733

Sources: Medicare National Coverage Determination (NCD) 240.2, Home Use of Oxygen (CMS); Local Coverage Determination (LCD) L33797, Oxygen and Oxygen Equipment, and associated DME-MAC policy article; Blue Cross Blue Shield of Michigan, Home Oxygen Equipment and Related Supplies medical policy (which BCBSM states aligns with Medicare NCD 240.2, excepting the 36-month rental limit). This article is clinical and administrative guidance, not a guarantee of coverage; verify current policy language and the member's specific benefit plan before ordering.